Literature DB >> 30082769

PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.

Fu-Chun Huo1,2, Yao-Jie Pan3, Tong-Tong Li1, Jie Mou4, Dong-Sheng Pei5,6.   

Abstract

p21-activated kinase 5 (PAK5) is involved in several oncogenic signaling pathways and its amplification or overexpression has been found in various types of cancer; however, the pathophysiologic role of PAK5 in cervical cancer (CC) remains elusive. This study aims to elucidate the effects of PAK5 on CC metastasis and its specific regulation mechanism. We performed western blotting and immunohistochemistry (IHC) analysis and found that the expression levels of PAK5 were significantly upregulated in CC cells and tissues. In addition, statistical analysis via IHC showed that increased PAK5 significantly correlated with CC progression. Mn2+-Phos-tag SDS-PAGE, western blotting, immunofluorescence and dual luciferase reporter assays were utilized to determine the involvement of SATB1 in PAK5-mediated epithelial-mesenchymal transition (EMT). We found that PAK5-mediated special AT-rich binding protein-1 (SATB1) phosphorylation on Ser47 initiated EMT cascade and promoted migration and invasion of CC cells. Furthermore, overexpression of PAK5 induced lung metastasis of CC cells in xenograft modes. Taken together, we conclude that PAK5 is a novel prognostic indicator and plays an important role in the CC metastasis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30082769      PMCID: PMC6748095          DOI: 10.1038/s41418-018-0178-4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

1.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

2.  Epithelial-mesenchymal transition in cervical carcinoma.

Authors:  Mei-Yi Lee; Meng-Ru Shen
Journal:  Am J Transl Res       Date:  2012-01-01       Impact factor: 4.060

3.  Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.

Authors:  Akhilesh Pandey; Ippeita Dan; Troels Z Kristiansen; Norinobu M Watanabe; Jesper Voldby; Eriko Kajikawa; Roya Khosravi-Far; Blagoy Blagoev; Matthias Mann
Journal:  Oncogene       Date:  2002-05-30       Impact factor: 9.867

4.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

5.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 6.  p21-Activated kinase 5: a pleiotropic kinase.

Authors:  Yi-Yang Wen; Xiao-Xia Wang; Dong-Sheng Pei; Jun-Nian Zheng
Journal:  Bioorg Med Chem Lett       Date:  2013-10-31       Impact factor: 2.823

7.  Hysterectomy in invasive cervical cancer: a national patterns of care study of the American College of Surgeons.

Authors:  H M Shingleton; W B Jones; A Russell; A Fremgen; J S Chmiel; K Ocwieja; D P Winchester; R Clive
Journal:  J Am Coll Surg       Date:  1996-10       Impact factor: 6.113

Review 8.  EMT in cervical cancer: its role in tumour progression and response to therapy.

Authors:  Rehana Qureshi; Himanshu Arora; M A Rizvi
Journal:  Cancer Lett       Date:  2014-09-30       Impact factor: 8.679

9.  Prognostic significance of the number of metastatic lymph nodes to stratify the risk of recurrence.

Authors:  Jeonghun Lee; Youngpeck Song; Euy Young Soh
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

10.  PAK signaling in cancer.

Authors:  Diana Zi Ye; Jeffrey Field
Journal:  Cell Logist       Date:  2012-04-01
View more
  14 in total

1.  MBD2 Correlates with a Poor Prognosis and Tumor Progression in Renal Cell Carcinoma.

Authors:  Liantao Li; Na Li; Nianli Liu; Fuchun Huo; Junnian Zheng
Journal:  Onco Targets Ther       Date:  2020-10-07       Impact factor: 4.147

2.  Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.

Authors:  Fu-Chun Huo; Wen-Tao Zhu; Xu Liu; Yun Zhou; Lan-Sheng Zhang; Jie Mou
Journal:  Invest New Drugs       Date:  2020-09-19       Impact factor: 3.850

3.  METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.

Authors:  Fu-Chun Huo; Zhi-Man Zhu; Wen-Tao Zhu; Qiu-Ying Du; Jia Liang; Jie Mou
Journal:  Oncogene       Date:  2021-03-23       Impact factor: 9.867

4.  Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling.

Authors:  Kang Zhu; He Bai; Mingzhu Mu; Yuanyuan Xue; Zhao Duan
Journal:  FEBS Open Bio       Date:  2021-06-18       Impact factor: 2.792

5.  Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.

Authors:  Damien Kaukonen; Riina Kaukonen; Lélia Polit; Bryan T Hennessy; Riikka Lund; Stephen F Madden
Journal:  BMC Med Genomics       Date:  2020-07-03       Impact factor: 3.063

6.  PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.

Authors:  Silin Huang; Ying Zhu; Chunfei Wang; Xiaxi Li; Xiaobing Cui; Sufang Tu; Lijuan You; JingWen Fu; Zemin Chen; Wei Hu; Wei Gong
Journal:  Cancer Med       Date:  2020-05-08       Impact factor: 4.452

7.  CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.

Authors:  Zun Mao; Miao-Miao Sang; Cheng Chen; Wen-Tao Zhu; Yu-Sen Gong; Dong-Sheng Pei
Journal:  Int J Biol Sci       Date:  2019-05-12       Impact factor: 6.580

8.  Therapeutic potential of targeting HSPA5 through dual regulation of two candidate prognostic biomarkers ANXA1 and PSAT1 in osteosarcoma.

Authors:  Xiaojun Tang; Lingli Luo; Yukun Li; Hailong Wu; Qing Hu; Haiyan Yue; Xiao He; Juan Zou; Shaoxiong Min
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

9.  P21-activated kinase 5 potentiates the chemoresistant phenotype of liver cancer.

Authors:  Ding-Guo Zhang; Chan-Chan Gong; Xiao-Jin Wu; Xin Ren; Randee S Sedaka; Wei-Cong Chen; Fu-Chun Huo; Cheng Chen; Wen-Qi Du; Dong-Sheng Pei
Journal:  Signal Transduct Target Ther       Date:  2021-02-05

10.  MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.

Authors:  Tong-Tong Li; Jie Mou; Yao-Jie Pan; Fu-Chun Huo; Wen-Qi Du; Jia Liang; Yang Wang; Lan-Sheng Zhang; Dong-Sheng Pei
Journal:  J Biomed Sci       Date:  2021-08-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.